Skip to main content
OpenTrials
Completed

NCT Number: NCT04925739

Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnea syndrome (OSA). It consists of a pressure generator connected to a mask applied to the patient's face. CPAP treatment is restrictive, and nearly a quarter of patients abandon it over the long term. Various factors can influence adherence to CPAP therapy, including adverse events associated with the mask. However, it is clear that compliance with CPAP treatment, even if it has tended to improve over the last 30 years, is still sub-optimal.

The "Air Liquide Medical Systems" company has developed a mask that aims to improve comfort and ease of use for the patient. This leaky nasal mask has a "silent" intentional leak port, which significantly reduces the noise caused by the escape of air. The noise associated with intentional leakage is one of the discomforts reported by patients and their spouses. In addition, this mask is equipped with a new generation headgear with adjustment indicators to assist the patient in fitting the mask. Optimal headgear fit is a prerequisite for comfort during treatment, as it reduces unintentional leakage.

The main objective is to evaluate, through a questionnaire, the comfort and general appreciation of a nasal mask equipped with a silent leak system and a headgear with adjustment aids, of patients with OSA treated with CPAP.

Secondary objectives are :

1. To evaluate the appearance of CPAP side effects related to the mask, 2. To collect the patient's appreciation of the mask headgear, 3. To evaluate the discomfort caused by the nasal obstruction reported by the patient, 4. To evaluate the daytime sleepiness of the patient, 5. To study the parameters of the CPAP treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Pauline Socquet

Meylan, 38240, France

About this study

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnea syndrome (OSA). It consists of a pressure generator connected to a mask applied to the patient's face. CPAP treatment is restrictive, and nearly a quarter of patients abandon it over the long term. Various factors can influence adherence to CPAP therapy, including adverse events associated with the mask. Unintentional leaks, i.e. a leak between the pressure generator and the patient's upper airway, are among the most frequent. Therefore, optimizing the choice of mask is one of the main means used by medical-technical providers, in charge of installing CPAP and its technical follow-up at home. In order to cover the needs and anatomical particularities of the OSA patient population treated with CPAP, a large number of mask types and sizes are currently available on the market. However, it is clear that compliance with CPAP treatment, even if it has tended to improve over the last 30 years, is still sub-optimal.

The "Air Liquide Medical Systems" company has developed a mask that aims to improve comfort and ease of use for the patient. This leaky nasal mask has a "silent" intentional leak port, which significantly reduces the noise caused by the escape of air. The noise associated with intentional leakage is one of the discomforts reported by patients and their spouses. In addition, this mask is equipped with a new generation headgear with adjustment indicators to assist the patient in fitting the mask. Optimal headgear fit is a prerequisite for comfort during treatment, as it reduces unintentional leakage.

The main objective is to evaluate, through a questionnaire, the comfort and general appreciation of a nasal mask equipped with a silent leak system and a headgear with adjustment aids, of patients with OSA treated with CPAP.

After 30 days of use, secondary objectives are :

  • To evaluate the appearance of CPAP side effects related to the mask (air leaks, injury to the nasal bridge, etc.)
  • To collect the patient's appreciation of the mask headgear, which includes indications to help with the installation in the form of graduated markers, as well as the appreciation of the general aesthetics of the mask.
  • To evaluate the discomfort caused by the nasal obstruction reported by the patient, in relation to the inclusion.
  • To evaluate the daytime sleepiness of the patient, compared to the inclusion.
  • To study the parameters of the CPAP treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patient over 18 years of age
  • Patient with OSA
  • Patient not previously treated with CPAP
  • A patient who will be treated with a "ResMed Airsense 10" CPAP and an "Air Liquide Medical Systems" NINA mask
  • Patient whose CPAP treatment will be installed and monitored by the home care provider AGIRADOM
  • Patient willing to participate in the research after adequate information and delivery of the information note
  • Patient affiliated to the social security system or beneficiary of such a system

Exclusion criteria

  • NOSE questionnaire score greater than or equal to 10/20 at the time of CPAP installation
  • Patient with significant craniofacial deformities that do not allow the mask to be fitted correctly
  • Person deprived of liberty by judicial or administrative decision, person under legal protection (patient under guardianship or curators) Article L1121-8
  • Subject who receives more than 4500 euros in compensation for his or her participation in other research involving the human person in the 12 months preceding this study

Treatment and study plan

Self-questionnaire on the comfort and general appreciation of a nasal mask

Other

Self-questionnaire on the comfort and general appreciation of a nasal mask after 30 days of use

Self-questionnaire on the appearance of CPAP side effects related to the mask

Other

Self-questionnaire on the appearance of CPAP side effects related to the mask (air leaks, injury to the nasal bridge, etc.) after 30 days of use

Self-questionnaire on the patient's appreciation of the mask headgear,

Other

Self-questionnaire NOSE (Nasal Obstruction Symptom Evaluation) on the patient's appreciation of the mask headgear, which includes indications to help with the installation in the form of graduated markers, as well as the appreciation of the general aesthetics of the mask, after 30 days of use.

Self-questionnaire NOSE on the discomfort caused by the nasal obstruction

Other

Self-questionnaire NOSE on the discomfort caused by the nasal obstruction reported by the patient, after 30 days of use, compared to the inclusion.

Self-questionnaire Epworth on the daytime sleepiness

Other

Self-questionnaire Epworth on the daytime sleepiness of the patient, after 30 days of treatment, compared to the inclusion.

To study the parameters of the CPAP treatment.

To study the CPAP compliance

Other

To collect the treatment compliance through telemonitoring of the data recorded by the CPAP machine, during the 30 days of treatment.

To study the unintentional leakage

Other

To collect the unintentional leakage estimated by the CPAP machine, during the 30 days of treatment.

To study the therapeutic pressures of CPAP

Other

To collect the therapeutic pressures of CPAP, during the 30 days of treatment.

Primary outcomes

  1. To evaluate the comfort and general appreciation of a nasal mask

    Time frame: After 30 days of CPAP treatment

    to evaluate, through a questionnaire, the comfort and general appreciation of a nasal mask equipped with a silent leak system and a headgear with adjustment aids, of patients with OSA treated with CPAP.

Secondary outcomes

  1. To evaluate the appearance of CPAP side effects related to the mask

    Time frame: After 30 days of CPAP treatment

    To evaluate the appearance of CPAP side effects, through a questionnaire, related to the mask (air leaks, injury to the nasal bridge, etc.)

  2. To collect the patient's appreciation of the mask headgear

    Time frame: After 30 days of CPAP treatment

    To collect, through a questionnaire, the patient's appreciation of the mask headgear, which includes indications to help with the installation in the form of graduated markers, as well as the appreciation of the general aesthetics of the mask.

  3. To evaluate the discomfort caused by the nasal obstruction reported by the patient

    Time frame: After 30 days of CPAP treatment

    To evaluate, trough the NOSE questionnaire, the discomfort caused by the nasal obstruction reported by the patient, compared to the inclusion.

  4. To evaluate the daytime sleepiness of the patient

    Time frame: After 30 days of CPAP treatment

    To evaluate the daytime sleepiness of the patient, through the Epworth questionnaire, compared to the inclusion.

  5. To collect the CPAP treatment compliance

    Time frame: During the 30 days of CPAP treatment

    To collect the treatment compliance (average daily use) through telemonitoring of the data recorded by the CPAP machine.

  6. To collect the unintentional leakage

    Time frame: During the 30 days of CPAP treatment

    To collect the unintentional leakage estimated by the CPAP machine.

  7. To collect the CPAP therapeutic pressures

    Time frame: During the 30 days of CPAP treatment

    To collect the CPAP therapeutic pressures used.

Sponsors and collaborators

Lead sponsor

AGIR à Dom

Other

Collaborators

  • Air Liquide SA

Registry information

Official study title

Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of Obstructive Sleep Apnea Syndrome

Acronym: NINADOM

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jun 14, 2021
Registry last updated
Feb 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.